Robin L. Smith - 03 Sep 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 03 Sep 2021
Net transaction value: +$785,250
SEC form: 4
Accepted by SEC: 03 Sep 2021, 17:36:54 UTC
Prior SEC filing: 30 Aug 2021
Next SEC filing: 13 Sep 2021
Source filing: View source filing
Reporting owner signature: /s/ Henry Ji, Ph.D., as Attorney-in-Fact

Key filing fact

Robin L. Smith filed Form 4 for Sorrento Therapeutics, Inc. on 03 Sep 2021.

Key facts

This page summarizes Robin L. Smith's Form 4 filing for Sorrento Therapeutics, Inc..
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 03 Sep 2021, 17:36.

Change

Previous filing in this sequence was filed on 30 Aug 2021.
Current net transaction value: +$785,250.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRNEQ transaction

Common Stock

Options Exercise

Transaction value: $296,250
Shares: +75,000
Change %: +125%
Price: $3.95
Shares after: 135,000
Date: 03 Sep 2021
Ownership: Direct

SRNEQ transaction

Common Stock

Options Exercise

Transaction value: $489,000
Shares: +100,000
Change %: +74%
Price: $4.89
Shares after: 235,000
Date: 03 Sep 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRNEQ transaction Derivative

Stock Options

Options Exercise

Transaction value: $0
Shares: -75,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Sep 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 75,000
Exercise price: $3.95
Footnotes: F1

SRNEQ transaction Derivative

Stock Options

Options Exercise

Transaction value: $0
Shares: -100,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Sep 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $4.89
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

1/12 of the original number of shares subject to this option vested and became exercisable on January 16, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.

Footnote F2

1/12 of the original number of shares subject to this option vested and became exercisable on July 15, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.